Literature DB >> 10584717

Albumin infusion for spontaneous bacterial peritonitis.

B A Runyon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10584717     DOI： 10.1016/S0140-6736(99)00303-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Clinical use of albumin in hepatology.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Antonio Gasbarrini
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

2.  Recommendations for the use of albumin and immunoglobulins.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

3.  Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Authors:  R Moreau; T Asselah; B Condat; C de Kerguenec; F Pessione; B Bernard; T Poynard; M Binn; J D Grangé; D Valla; D Lebrec
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 4.  TIPS versus paracentesis for cirrhotic patients with refractory ascites.

Authors:  S Saab; J M Nieto; S K Lewis; B A Runyon
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

Authors:  Tarsila Cr Ribeiro; Julio Mf Chebli; Mario Kondo; Pedro Duarte Gaburri; Liliana Andrade Chebli; Ana Cristina Amaral Feldner
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

Review 6.  Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis.

Authors:  Chun Shing Kwok; Lukasz Krupa; Ash Mahtani; Duncan Kaye; Simon M Rushbrook; Martin G Phillips; William Gelson
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.